CLOSE

Specials

  • March
  • June
  • September
  • Bioanalytical Services
  • Life Science Analytics
  • Life Science Compliance
  • Bioanalytical Services APAC
  • APAC
  • Europe

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
APAC
  • Home
  • News
  • Contributors
  • Magazine
  • Conferences
  • Newsletter
  • About

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Must-Know Biotechnology Trends in 2021

Must-Know Biotechnology Trends in 2021

Top Biotech Developments to Watch for

Top Biotech Developments to Watch for

Using AI to Prevent Adverse Effects of Immunotherapy

Using AI to Prevent Adverse Effects...

Ehave, Inc. Uses Artificial Intelligence And Machine Learning for Big Data Management in Mental Health Care

Ehave, Inc. Uses Artificial...

The Role of Technology in the Biotech Sector

The Role of Technology in the Biotech...

Cyberattacks in Hospitals

Cyberattacks in Hospitals

How AI Can Enhance the Prediction of Immunotherapy

How AI Can Enhance the Prediction of...

How Technology is Reshaping Immunotherapy

How Technology is Reshaping...

Must-Know Biotechnology Trends in 2021

Must-Know Biotechnology Trends in 2021

Top Biotech Developments to Watch for

Top Biotech Developments to Watch for

Using AI to Prevent Adverse Effects of Immunotherapy

Using AI to Prevent Adverse Effects...

Ehave, Inc. Uses Artificial Intelligence And Machine Learning for Big Data Management in Mental Health Care

Ehave, Inc. Uses Artificial...

The Role of Technology in the Biotech Sector

The Role of Technology in the Biotech...

Cyberattacks in Hospitals

Cyberattacks in Hospitals

How AI Can Enhance the Prediction of Immunotherapy

How AI Can Enhance the Prediction of...

How Technology is Reshaping Immunotherapy

How Technology is Reshaping...

The Life Sciences Industry Outlook

By Life Sciences Review | Monday, July 20, 2020
Tweet

Interoperability, patient experience, and inclusive clinical trials are trends expected to shape the future of life sciences companies in the coming years.


FREMONT, CA: The life sciences industry is at an inflection point. To prepare for the future and remain competitive in the ever-evolving business landscape, life sciences organizations are looking for new ways to create value and new metrics to make sense. Here is a look at the factors driving these changes and outlines suggestions on how life sciences organizations can aspire to find real value for themselves in the coming years. 


Based on the massive volume of available data and needs to be analyzed, radical interoperability is the ultimate vision of life sciences companies today. To achieve interoperability of massive quantities of data, created by regulators, customers, patients, doctors, and caregivers, and produced by wearable devices, sensors, life sciences companies this year will likely spend more time exploring cloud platforms. Health data, coupled with AI, could also lead to the development of personalized electronic health that can fundamentally change the patient experience and the human experience.


 


Technology companies are likely to enter the life sciences sector in 2020, possibly even faster than in previous years. They might create new internet-connected devices. Some healthcare companies are already functioning using AI and interoperable data, building architectures, and platforms where future data will reside. Many large health systems have announced plans to migrate their clinical data to cloud platforms run by large technology companies. Cloud storage combined with AI will likely accelerate the pace of medical research, which could lead to more precise treatments and cures.


Clinical trials are essential to medical research, but they must represent the patients who will use the drug or therapy to have statistical value. As such, today's life sciences companies are looking to change the way they think about the clinical-trial model. It appears that more companies will experiment with mobile-driven clinical trial models to reach larger, diverse populations if companies reimagine the way these trials are run. The life sciences industry moves closer to the promise of true precision medicine and a future of health. 2020 is likely to be seen as the year life sciences companies finally move past their 20th-century models and step into a new era.


See also: Top Cloud Based Planning Companies


 


Weekly Brief

loading
Towards a New World Order
> <
  • Other 2021

    Top Vendors

    Current Issue
  • Other 2020

    Top Vendors

    Current Issue

Read Also

Critical Bioanalytical Challenges of ADCs

Critical Bioanalytical Challenges of ADCs

Must-Know Biotechnology Trends in 2021

Must-Know Biotechnology Trends in 2021

Top Biotech Developments to Watch for

Top Biotech Developments to Watch for

Importance of Biomarkers in Drug Development

Importance of Biomarkers in Drug Development
Using AI to Prevent Adverse Effects of Immunotherapy

Using AI to Prevent Adverse Effects of Immunotherapy

Ehave, Inc. Uses Artificial Intelligence And Machine Learning for Big Data Management in Mental Health Care

Ehave, Inc. Uses Artificial Intelligence And Machine Learning for Big Data Management in Mental Health Care

The Role of Technology in the Biotech Sector

The Role of Technology in the Biotech Sector

Why Partner with Bioanalysis Experts?

Why Partner with Bioanalysis Experts?
Loading...

Copyright © 2021 Life Science Review . All rights reserved. |  Subscribe follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/the-life-sciences-industry-outlook--nwid-83.html